What is the current price for "Will the FDA approve VERVE-102?"?

The leading outcome "Yes" is currently trading at 82.5% probability.

How many markets are available for "Will the FDA approve VERVE-102?"?

There are 6 markets available for this event on Kalshi.

What is the trading volume for "Will the FDA approve VERVE-102?"?

Trading volume data is not currently available.

BackKKALSHI

Will the FDA approve VERVE-102?

Yes83%

Vol$0.00

Markets6

83%

TradeTrade on Kalshi

Event Group

EventKALSHI

Single EventKALSHIScience and Technology

Will the FDA approve VERVE-102?

Name: Will the FDA approve VERVE-102?
Start: 2026-07-10T09:46:33.233Z
End: 2026-08-09T09:46:33.233Z

Part of: Will the FDA approve VERVE-102?

VERVE-102 If the FDA approves VERVE-102 for marketing before Jan 1, X then the market resolves to Yes. An approval is defined as: For new drugs: FDA issuance of an approval letter for a New Drug Application, NDA, or Biologics License Application, BLA, For already-marketed drugs seeking new indications: FDA approval of a supplemental NDA, sNDA, or supplemental BLA, sBLA, for the specific indication referenced For generic drugs: FDA approval of an Abbreviated New Drug Application, ANDA, For biosi

YesLeading Yes Probability

83%

VolTotal Volume

$0.00

Markets

Trade on Kalshi

Will the FDA approve VERVE-102?

Yes

83%

Vol

$0.00

Markets

Trade

Market Price Graph

6 markets tracked

Will the FDA approve VERVE-102 before Jan 1, 2035?

kalshi

No data available

All Markets(6)

Market	Price
Will the FDA approve VERVE-102 before Jan 1, 2035?	83%
Will the FDA approve VERVE-102 before Jan 1, 2034?	78%
Will the FDA approve VERVE-102 before Jan 1, 2033?	75%
Will the FDA approve VERVE-102 before Jan 1, 2032?	71%
Will the FDA approve VERVE-102 before Jan 1, 2031?	65%

Markets (6)

Sort

KALSHIHealth

Will the FDA approve VERVE-102 before Jan 1, 2035?

If the FDA approves VERVE-102 for marketing before Jan 1, 2035, then the market resolves to Yes. Secondary rules: An approval is defined as: For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed drugs seeking n

Will the FDA approve VERVE-102 before Jan 1, 2034?

If the FDA approves VERVE-102 for marketing before Jan 1, 2034, then the market resolves to Yes. Secondary rules: An approval is defined as: For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed drugs seeking n

Will the FDA approve VERVE-102 before Jan 1, 2033?

If the FDA approves VERVE-102 for marketing before Jan 1, 2033, then the market resolves to Yes. Secondary rules: An approval is defined as: For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed drugs seeking n

Will the FDA approve VERVE-102 before Jan 1, 2032?

If the FDA approves VERVE-102 for marketing before Jan 1, 2032, then the market resolves to Yes. Secondary rules: An approval is defined as: For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed drugs seeking n

Will the FDA approve VERVE-102 before Jan 1, 2031?

If the FDA approves VERVE-102 for marketing before Jan 1, 2031, then the market resolves to Yes. Secondary rules: An approval is defined as: For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed drugs seeking n

Will the FDA approve VERVE-102 before Jan 1, 2030?

If the FDA approves VERVE-102 for marketing before Jan 1, 2030, then the market resolves to Yes. Secondary rules: An approval is defined as: For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed drugs seeking n